Together, these two organizations offer capabilities in anatomic pathology and molecular biology, microbiology, virology and protein chemistry services for the biopharmaceutical industry. These services are offered individually or can be integrated to support product development from discovery-to-market.
“The unique combination of these organizations creates a single-source laboratory that brings together the highest level of expertise in all forms of laboratory science,” said William Miller, CEO of AIBioTech.
Krystyna Drewnowska-Coates, Ph.D., executive vice president of Bostwick Scientific, added, “This expertise can then be utilized in all types of clinical trials—from anatomic pathology to genetics.”
